These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29358222)

  • 1. Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
    Czoli CD; Hammond D
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):262-267. PubMed ID: 29358222
    [No Abstract]   [Full Text] [Related]  

  • 2. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
    Czoli CD; Hammond D
    Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
    Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
    Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
    Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
    Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.
    Wei B; Blount BC; Xia B; Wang L
    J Expo Sci Environ Epidemiol; 2016; 26(3):249-56. PubMed ID: 25564369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
    Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
    Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
    Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSNA exposure from cigarette smoking: 18 years of urinary NNAL excretion data.
    Appleton S; Olegario RM; Lipowicz PJ
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):269-74. PubMed ID: 23920111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
    Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents.
    Jacob P; St Helen G; Yu L; Nardone N; Havel C; Cheung P; Benowitz NL
    Nicotine Tob Res; 2020 Jun; 22(7):1107-1113. PubMed ID: 31833541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Urine 4-(Methylnitrosamino)-1-(3)Pyridyl-1-Butanol and Cotinine for Assessment of Active and Passive Smoke Exposure in Urban Adolescents.
    Benowitz NL; Nardone N; Jain S; Dempsey DA; Addo N; St Helen G; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):254-261. PubMed ID: 29475963
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends Over Time in Tobacco-Specific Nitrosamines (TSNAs) in Whole Tobacco and Smoke Emissions From Cigarettes Sold in Canada.
    Czoli CD; Hammond D
    Nicotine Tob Res; 2018 Apr; 20(5):649-653. PubMed ID: 28595283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
    Chen G; Luo S; Kozlovich S; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
    Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.